Close Menu

Frustrating, Yes

Mike the Mad Biologist writes on his blog that there's some not so high-quality genome annotation in GenBank. Annotation, he says, hadn’t been the rate-limiting step until recently in sequencing and now that it is, many labs are turning to automated gene prediction software. However, he adds that software correctly calls about 95 percent of genes and that not all labs have check in place to find bad calls.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.